SAN DIEGO, June 5, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech company, today announced its chief financial officer David Ramsay will retire this summer, and …
Continue Reading about Halozyme Announces Plans For CFO Transition, Names Laurie Stelzer CFO →